Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Hristo Svilenov

ORCID iD: 0000-0001-5863-9569

Add to list
- Journal Article
- A1
- open access
Principles of antibodies with ultralong complementarity-determining regions and picobodies

Marcel Fridolin Passon (UGent) , Stefaan De Smedt (UGent) and Hristo Svilenov (UGent)

(2023) BIOTECHNOLOGY ADVANCES. 64.
Add to list
- Journal Article
- A1
- open access
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

Hristo Svilenov (UGent) , Paolo Arosio, Tim Menzen, Peter Tessier and Pietro Sormanni

(2023) MABS. 15(1).
Add to list
- Miscellaneous
- open access
Get what you want : identifying antibodies against pre-defined epitopes on Frizzled receptors

Hristo Svilenov (UGent)

(2023) STRUCTURE. 31(1). p.2-3
Add to list
- Journal Article
- A1
- open access
Insights into the stabilization of interferon alpha by two surfactants revealed by STD-NMR spectroscopy

Hristo Svilenov (UGent) , Katharina T. Kopp, Alexander P. Golovanov, Gerhard Winter and Matja Zalar

(2023) JOURNAL OF PHARMACEUTICAL SCIENCES. 112(2). p.404-410
Add to list
- Journal Article
- A1
- open access
Antibodies gone bad : the molecular mechanism of light chain amyloidosis

Ramona M. Absmeier, Georg J. Rottenaicher, Hristo Svilenov (UGent) , Pamina Kazman and Johannes Buchner

(2023) FEBS JOURNAL. 290(6). p.1398-1419
Add to list
- Journal Article
- A1
- open access
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

Hristo Svilenov (UGent) , Romina Bester, Julia Sacherl, Ramona Absmeier, Carsten Peters, Ulrike Protzer, Carsten Brockmeyer and Johannes Buchner

(2022) COMMUNICATIONS BIOLOGY. 5(1).
Add to list
- Journal Article
- A1
- open access
It is never too late for a cocktail : development and analytical characterization of fixed-dose antibody combinations

Dennis Krieg, Gerhard Winter and Hristo Svilenov (UGent)

(2022) JOURNAL OF PHARMACEUTICAL SCIENCES. 111(8). p.2149-2157
Add to list
- Journal Article
- A1
- open access
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein

Hristo Svilenov (UGent) , Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng, Marcel Stern, Vincent Grass, Martin Feuerherd, Frank-Peter Wachs, Nicole Simonavicius, et al.

(2021) ANTIVIRAL RESEARCH. 196.
Add to list
- Journal Article
- A1
- open access
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design

Hristo Svilenov (UGent) , Julia Sacherl, Ulrike Protzer, Martin Zacharias and Johannes Buchner

(2021) NATURE COMMUNICATIONS. 12(1).
Add to list
Combining unfolding reversibility studies and molecular dynamics simulations to select aggregation-resistant antibodies

Carolin Berner, Tim Menzen, Gerhard Winter and Hristo Svilenov (UGent)

(2021) MOLECULAR PHARMACEUTICS. 18(6). p.2242-2253

1
2
3

Next →